cardiovascular-agents and Essential-Hypertension

cardiovascular-agents has been researched along with Essential-Hypertension* in 13 studies

Other Studies

13 other study(ies) available for cardiovascular-agents and Essential-Hypertension

ArticleYear
[Optimization of pharmacotherapy in patients with essential hypertension with neurohumoral modulators with consideration of data on heart rate variability].
    Kardiologiia, 2013, Volume: 53, Issue:12

    Long-term treatment of patients with essential hypertension (EH) and autonomic dysfunction (sympathicotonia type) with lisinopril in combination with indapamide augmented activity of humoral systems and improved heart rate variability. Addition of a selective beta-blocker bisoprolol to lisinopril/indapamide combination promoted normalization of humoral activity. This gives reason to apply tiered RAAS blockade in order to ensure more effective control of activity of neurohumoral systems in patients with EH ant initial sympathicotonia.

    Topics: Adult; Antihypertensive Agents; Cardiovascular Agents; Data Interpretation, Statistical; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Essential Hypertension; Female; Heart Rate; Humans; Hypertension; Indapamide; Lisinopril; Male; Neurotransmitter Agents; Severity of Illness Index; Sympathetic Nervous System; Treatment Outcome

2013
A double-blind study of essential hypertension.
    Journal of the Mississippi State Medical Association, 1960, Volume: 1

    Topics: Cardiovascular Agents; Double-Blind Method; Ergot Alkaloids; Essential Hypertension; Hypertension

1960
[Clinical experiences with raupental in the long term treatment of essential hypertension].
    Wiener medizinische Wochenschrift (1946), 1958, Feb-22, Volume: 108, Issue:8

    Topics: Antihypertensive Agents; Cardiovascular Agents; Essential Hypertension; Hypertension; Muscle Relaxants, Central; Secologanin Tryptamine Alkaloids

1958
[Some experience from treating essential hypertension with hydergine].
    Acta medica Scandinavica. Supplementum, 1956, Volume: 312

    Topics: Cardiovascular Agents; Ergoloid Mesylates; Ergot Alkaloids; Essential Hypertension; Hypertension; Oxytocics

1956
[Treatment of essential hypertension by hydergine].
    Turk Tip Cemiyeti mecmuasi, 1954, Volume: 20, Issue:2

    Topics: Cardiovascular Agents; Ergoloid Mesylates; Ergot Alkaloids; Essential Hypertension; Hypertension; Oxytocics

1954
Hexamethonium compounds in the treatment of pre-eclampsia and essential hypertension during pregnancy.
    Lancet (London, England), 1953, Feb-14, Volume: 1, Issue:6755

    Topics: Cardiovascular Agents; Essential Hypertension; Female; Hexamethonium Compounds; Hypertension; Muscle Relaxants, Central; Pre-Eclampsia; Pregnancy; Pregnancy Complications

1953
Essential hypertension; treatment with hexamethonium and apresoline.
    United States Armed Forces medical journal, 1953, Volume: 4, Issue:6

    Topics: Cardiovascular Agents; Essential Hypertension; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics

1953
Dihydrogenated ergot alkaloids (hydergine) in the treatment of essential hypertension.
    Acta medica Scandinavica, 1953, Volume: 145, Issue:3

    Topics: Cardiovascular Agents; Ergoloid Mesylates; Ergot Alkaloids; Essential Hypertension; Hypertension; Oxytocics

1953
[Pathogenesis and therapy of essential hypertension].
    Imprensa medica, 1953, Volume: 28, Issue:465

    Topics: Cardiovascular Agents; Ergot Alkaloids; Essential Hypertension; Hypertension; Oxytocics

1953
Continous oral hexamethonium in essential hypertension; further experiences in treatment.
    Glasgow medical journal, 1952, Volume: 33, Issue:10

    Topics: Cardiovascular Agents; Essential Hypertension; Hexamethonium; Hypertension; Muscle Relaxants, Central

1952
[Results of surgical therapy in essential hypertension].
    Nederlands tijdschrift voor geneeskunde, 1952, Nov-22, Volume: 96, Issue:47

    Topics: Cardiovascular Agents; Essential Hypertension; Hypertension; Muscle Relaxants, Central

1952
Dihydrogenated ergot alkaloids in the treatment of essential hypertension.
    Circulation, 1952, Volume: 5, Issue:2

    Topics: Cardiovascular Agents; Ergot Alkaloids; Essential Hypertension; Hypertension

1952
[Hydrogenated derivatives of Secale cornutum in the treatment of essential hypertension; research].
    Minerva medica, 1951, Sep-29, Volume: 42, Issue:64

    Topics: Cardiovascular Agents; Ergot Alkaloids; Essential Hypertension; Humans; Hypertension; Research; Secale

1951